Quarterly ResultJul 24, 2026, 07:51 AM
HCA Healthcare Q2 Revenue $20.23B, EPS $7.62; Lowers 2026 Guidance
AI Summary
HCA Healthcare reported strong second-quarter 2026 results with revenues up 8.7% to $20.230 billion and diluted EPS increasing 11.6% to $7.62. However, the company revised its full-year 2026 guidance downwards for revenues, net income, Adjusted EBITDA, and EPS, citing an increased unfavorable impact from payer mix shifts due to health insurance exchanges. The Board also declared a quarterly cash dividend of $0.78 per share.
Key Highlights
- Q2 2026 Revenues increased 8.7% to $20.230 billion.
- Q2 2026 Diluted EPS increased 11.6% to $7.62 per share.
- Q2 2026 Net income attributable to HCA Healthcare, Inc. rose 2.8% to $1.699 billion.
- Q2 2026 Adjusted EBITDA increased 4.6% to $4.027 billion.
- Board declared a quarterly cash dividend of $0.78 per share.
- Revised 2026 Diluted EPS guidance to $28.70-$30.50 (previously $29.10-$31.50).
- Payer mix shift had an unfavorable $400 million impact on Q2 income before taxes.
- Medicaid Supplemental Payment Programs provided $400 million incremental net benefit in Q2.
Price Impact
More from HCA